Foreground Capital
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- United States
Investment stages
- Seed
- Series A
- Series B
Industries
- Women's Health
- Biopharma
- Medical Devices
- Diagnostics
- Digital Health
- Tech-Enabled Services
- Consumer Health
- Maternal Health
- Reproductive Health
About
Foreground Capital is a San Francisco-based venture capital firm focused on backing early-stage women's health companies across the care continuum. Their focus spans biopharma, devices, diagnostics, digital health, and consumer health across the United States, with a second office in Boston. Founded in 2024 as successor to RH Capital, the firm supports women's health founders from seed through Series B.
Foreground Capital is a San Francisco-based venture capital firm focused on backing early-stage women's health companies across the care continuum. Their focus spans biopharma, devices, diagnostics, digital health, and consumer health across the United States, with a second office in Boston. Founded in 2024 as successor to RH Capital, the firm supports women's health founders from seed through Series B.
Investment Thesis
Foreground Capital is a seed to Series B venture capital firm deploying capital across biopharma, medical devices, diagnostics, digital health, tech-enabled services, and consumer health. They invest exclusively in companies addressing conditions that affect women directly and disproportionately, targeting reproductive health, maternal care, chronic conditions, mental health, and preventive care. The firm differentiates itself through continuity with predecessor funds at RH Capital, which built one of the largest dedicated women's health venture portfolios in the market.
Manager's Experience
Founded by Halle Tecco (Founding Partner, former Founder of Rock Health, Yale MBA), Jenny Abramson (Co-founder Rethink Impact), Cara Nakamura (Partner), and Christina Farr (Partner, former CNBC health tech journalist and Series X Capital). Fund I closed at $34.5M in November 2023 (oversubscribed from $30M target). Focused on women's health and healthcare companies.
Foreground Capital Contacts Information
Primary contact
Team
Elizabeth Bailey-Co-founder & Managing Partner
Stasia Obremskey-Co-founder & Managing Partner
Alice Zheng-Partner
Yvanka de Soysa-Associate
Molly Ward-Chief of Staff
Portfolio
AOA Dx
Bloomlife
Cadence OTC
Cirqle Biomedical
Cofertility
Contraline
Eli Health
Evvy
Gesynta Pharma
Mae
Millie
Nadia Care
Neuspera
Novocuff
Nurx
OCON Medical
Ovia Health
Planera
Raydiant Oximetry
Seven Starling
Testmate Health
Twentyeight Health
Vitra Labs
YourChoice Therapeutics
Cayaba Care